# Convalescent Plasma as a Possible Treatment for COVID-19

> **NCT04442191** · PHASE2 · RECRUITING · sponsor: **University of Illinois at Chicago** · enrollment: 50 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** Convalescent plasma
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04442191
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-05-05
- **Primary completion:** 2021-05-05
- **Final completion:** 2021-05-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04442191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04442191, "Convalescent Plasma as a Possible Treatment for COVID-19". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04442191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*